HOME > MARKETS > MARKET COMMENTARY
  MARKET COMMENTARY
EQUITY
Natco Pharma to acquire significant stake in Adcock Ingram
Oct-13-2025

Natco Pharma is planning to acquire significant stake in 135-year-old South African pharmaceutical giant Adcock Ingram. The South African Rand 4.2-billion deal will see Adcock Ingram becoming a privately-held entity co-owned by Natco and Bidvest, which will remain the majority shareholder in the group.

A meeting of shareholders of Adcock Ingram approved Natco's proposal to acquire all the ordinary shares in the company. Natco Pharma will acquire all the ordinary shares in Adcock Ingram through its subsidiary -- Natco Pharma South Africa. 

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

  RELATED NEWS >>